SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
736 All, Both Lehman and Bear Stern made positive comments and raised the price (iHong-Lee Yu-9/14/1998
735 I kind of expect some profit taking tomorrow or next day. I'm sticking withwpckr-9/13/1998
734 Hong-Lee and all: Two very solid, upward, high volume days; new high; day endiSDR-SI-9/11/1998
733 Another 11% today. Congratulations to all longs. Hong-Lee Yu-9/11/1998
732 Another upgrade from CIBC. Note that Matt Geller estimated BGEN will earn 51C Hong-Lee Yu-9/10/1998
731 Steven, I agreed. This agreement is a win-win situation for both companies to Hong-Lee Yu-9/9/1998
730 Hong-Lee: I, too, was a bit surprised that there are estimated to be so few MSSDR-SI-9/9/1998
729 No way. The CEOs of the two companies are friendly, but the companies have veryHarold Engstrom-9/9/1998
728 Could such a relationship with an outfit like GENZ be portent of the future? Pewpckr-9/9/1998
727 MS is a disease that afflicts mainly those with nordic and northern european etHarold Engstrom-9/9/1998
726 Steven, Cannot believe there in only 5000 or so MS patients in Japan. Pretty Hong-Lee Yu-9/9/1998
725 More AVONEX news: <b>> > >Genzyme to Commercialize and DistribuSDR-SI-9/9/1998
724 Goldman Sache's timely upgrade is a smart move. With the likely chances of Hong-Lee Yu-9/8/1998
723 MORE RECOMMENDATIONS: >>> RESEARCH ALERT - Goldman SDR-SI-9/8/1998
722 It appears Teva had submitted their data to the FDA regarding Copaxone's efHarold Engstrom-9/3/1998
721 I have a small position in BGEN and would like to increase it. Does anyone knoTom DuBois-9/2/1998
720 Due diligence is tough to do on any company. Biotech and pharmaceutical companHarold Engstrom-9/1/1998
719 Thank you, Harold. So much goes on with these kind of outfits it takes a while wpckr-8/31/1998
718 Hirulog was developed by Biogen and licensed to The Medicines Company. If TMC Harold Engstrom-8/31/1998
717 My dumb, what does this release have to do with BGEN? wpckr-8/31/1998
716 TO ALL: New Release RE: Possibl Progress In Turning Hirulog into $$$ > &gSDR-SI-8/31/1998
715 Harold, We'll know this in about 45 days (Q3 results). One thing for surHong-Lee Yu-8/26/1998
714 Maybe someone can further clarify this point. I think the press release distinHarold Engstrom-8/26/1998
713 Harold, I am just not sure that if I am a MS patient, do I get one prescriptioHong-Lee Yu-8/26/1998
712 "new IMS Health data showing new U.S. weekly prescriptions of Avonex hit 1Harold Engstrom-8/26/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News